176 related articles for article (PubMed ID: 20859651)
21. [Germ cell and embryonal tumors].
Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A
Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740
[TBL] [Abstract][Full Text] [Related]
23. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
[TBL] [Abstract][Full Text] [Related]
24. Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.
Bernstock JD; Alva E; Cohen JL; Lobbous M; Chagoya G; Elsayed GA; Orr BA; Rozzelle C; Rocque B; Blount J; Johnston JM; Li R; Fiveash JB; Dhall G; Reddy AT; Friedman GK
Pediatr Blood Cancer; 2020 Mar; 67(3):e28119. PubMed ID: 31850678
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.
Peyrl A; Sauermann R; Chocholous M; Azizi AA; Jäger W; Höferl M; Slavc I
Clin Pharmacokinet; 2014 Feb; 53(2):165-73. PubMed ID: 24129691
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
García-Recio M; Cladera A; Bento L; Dominguez J; Ruiz de Gracia S; Sartori F; Del Campo R; García L; Ballester C; Gines J; Bargay J; Sampol A; Gutiérrez A
PLoS One; 2017; 12(6):e0179595. PubMed ID: 28665999
[TBL] [Abstract][Full Text] [Related]
27. Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013.
Fairley L; Picton SV; McNally RJ; Bailey S; McCabe MG; Feltbower RG
Eur J Cancer; 2016 Jul; 61():36-43. PubMed ID: 27151553
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.
Navajas A; Lassaletta A; Morales A; López-Ibor B; Sábado C; Moscardó C; Mateos E; Molina J; Sagaseta M; Sastre A
Clin Transl Oncol; 2012 Apr; 14(4):280-6. PubMed ID: 22484635
[TBL] [Abstract][Full Text] [Related]
29. Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
Aichberger KJ; Herndlhofer S; Agis H; Sperr WR; Esterbauer H; Rabitsch W; Knöbl P; Haas OA; Thalhammer R; Schwarzinger I; Sillaber C; Jäger U; Valent P
Eur J Clin Invest; 2007 Oct; 37(10):808-13. PubMed ID: 17727673
[TBL] [Abstract][Full Text] [Related]
30. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.
Campen CJ; Dearlove J; Partap S; Murphy P; Gibbs IC; Dahl GV; Fisher PG
J Neurooncol; 2012 Nov; 110(2):287-91. PubMed ID: 22941430
[TBL] [Abstract][Full Text] [Related]
31. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
32. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system prophylaxis with intrathecal liposomal cytarabine in diffuse large B-cell lymphomas.
Krawczyk K; Jurczak W; Długosz-Danecka M; Zauska-Giza A; Dzietczenia J; Wróbel T; Skotnicki AB
Pol Arch Med Wewn; 2013; 123(11):589-95. PubMed ID: 23928849
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
35. Extraneural metastasis in intracranial tumors in children: the experience of a single center.
Varan A; Sari N; Akalan N; Söylemezoğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
J Neurooncol; 2006 Sep; 79(2):187-90. PubMed ID: 16645723
[TBL] [Abstract][Full Text] [Related]
36. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
37. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
[TBL] [Abstract][Full Text] [Related]
38. The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.
Arkenau HT; Chong G; Cunningham D; Watkins D; Agarwal R; Sirohi B; Trumper M; Norman A; Wotherspoon A; Horwich A
Ann Oncol; 2007 Mar; 18(3):541-5. PubMed ID: 17164228
[TBL] [Abstract][Full Text] [Related]
39. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
[TBL] [Abstract][Full Text] [Related]
40. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.
Segot A; Raffoux E; Lengline E; Thieblemont C; Dombret H; Boissel N; Cluzeau T
Ann Hematol; 2015 Nov; 94(11):1859-63. PubMed ID: 26280395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
